Balixafortide TFA
| Supplier | MedChemExpress |
|---|---|
| Product # | HY-P1682A-50 mg |
| Pricing | 50 mg, USD $1050.0 |
| Synonyms | POL6326 TFA |
| MWt | 1978.16 |
| Formula | C₈₆H₁₁₉F₃N₂₄O₂₃S₂ |
| Biological Activity | Balixafortide TFA (POL6326 TFA) is a potent, selective, well-tolerated peptidic CXCR4 antagonist with an IC50 < 10 nM. Balixafortide TFA shows 1000-fold selective for CXCR4 than a large panel of receptors including CXCR7. Balixafortide TFA blocks β-arrestin recruitment and calcium flux with IC50s < 10 nM. Balixafortide TFA is also a potent hematopoietic stem and progenitor cell (HSPC) mobilizing agent. Anti-cancer effects[1][2]. |
| Purity | 98.19% |